Multicohort phase 2 study of pembrolizumab for relapsed/refractory classical Hodgkin lymphoma (R/R Chl): Keynote-087.
Moskowitz, C Zinzani, P Fanale, M Armand, P Johnson, N Ribrag, V Radford, John A von Tresckow, B Tomita, A Shipp, M
Moskowitz, C
Zinzani, P
Fanale, M
Armand, P
Johnson, N
Ribrag, V
Radford, John A
von Tresckow, B
Tomita, A
Shipp, M
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Multicohort phase 2 study of pembrolizumab for relapsed/refractory classical Hodgkin lymphoma (R/R Chl): Keynote-087. 2016, 101:319-319 Haematologica